How Family Offices Are Funding The Next Wave Of Medical Research copertina

How Family Offices Are Funding The Next Wave Of Medical Research

How Family Offices Are Funding The Next Wave Of Medical Research

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A proposito di questo titolo
 Family offices are shifting capital from traditional real estate and farmland into the high-risk, high-reward world of private medical research. In this episode, we look at how independent wealth managers are bypassing venture capital bottlenecks to fund early-stage biotech trials directly. We examine the specific case of a mid-sized office in Connecticut that allocated five percent of its portfolio to direct clinical-stage investments in gene therapy, and why this structural shift is changing the timeline for drug development. We also discuss the liquidity constraints these investors face when their assets cannot be sold on public exchanges. #FamilyOffice #PrivateCapital #BiotechInvesting #MedicalResearch #DirectInvestment #GeneTherapy #ClinicalTrials #WealthManagement #HealthcareInnovation #VentureDebt #LongevityEconomy #PrivateEquity #RiskManagement #Pharmaceuticals #FexingoBusiness #BusinessPodcast #FinanceNews #GenerationalWealth Keep every episode free: buymeacoffee.com/fexingo
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione